Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.460 | A prospective, Single-center, Single-arm study to evaluate the safety and effectiveness of a long partially covered metal stent with hot delivery system (Hot Giobor) for EUS-guided hepatico-gastrostomy in patients with malignant biliary obstruction | Dr. CHAN Shannon Melissa |
| 2022.097 | Comparing clinical utility of serum CA 72-4 level with CEA and CA 19-9 in monitoring gastric cancer treatment. |
Dr. CHAN Shannon Melissa 陳詩瓏 |
| 2023.294 | Upfront endoscopic ultrasound-guided celiac plexus neurolysis versus conventional step-up approach for patients with painful, inoperable pancreatic cancer |
Dr. CHAN Shannon Melissa 陳詩瓏 |
| 2022.304 | Magnetic microrobots for biofilm eradication in biliary stents | Dr. CHAN Shannon Melissa |
| 2022.518 | Upfront EUS-guided gallbladder drainage versus standard protocol (antibiotics first) for mild to moderate acute cholecystitis in patients who are very-high-risk for cholecystectomy: A randomized-controlled trial. | Dr. CHAN Shannon Melissa |
| 2020.200 | What kind of personal protective equipment (PPE) is required for upper endoscopy, colonoscopy and laparoscopy during the COVID-19 pandemic? | Dr. CHAN Shannon Melissa |
| 2024.436 | Outcomes of Conversion Gastrectomy in Metastatic Gastric Cancer |
Dr. CHAN Shannon Melissa 陳詩瓏 |
| 2009.284 | Quality nursing care as perceived by nurses and patients in intensive care unit in Hong Kong | Mrs. Chan Sharon Ka Lam |
| 2011.342 | Cross sectional study on social Anxiety disorder in First-episode psychosis: prevalence, relationship with parania and perceived shame from psychosis | Dr. CHAN Sheung Chun |
| 2025.230 | Implementing Nurse-Led Ward Rounds in the Oncology Ward in Hong Kong | Ms. CHAN Sheung LIng |
| 2013.373 | Restless Legs Syndrome in Chinese Psychiatric Population: a cross-sectional study on its prevalence and clinical correlates | Dr. Chan Sheung Yan |
| 2009.526 | A Phase 2B, randomized, double-blind, placebo-controlled, dose ranging study evaluating the efficacy and safety of tanezumab for the treatment of moderate to severe pain associated with interstitial cystitis / painful bladder syndrome (IC/PBS) | Dr. Chan Shing Chee |
| 2014.313 | Psychiatric Morbidity in Hong Kong Chinese Women with Urodynamic Stress Incontinence attending an Outpatient Urodynamic Study Clinic | Dr Chan Shing Chee Symphorosa |
| 2011.045 | The prevalence of anal sphincter injury following childbirth and a cmparison of using endoanal ultrasound and translabial ultrasound in detecting anal sphincter injury | Consultant CHAN Shing Chee, Symphorosa |
| 2007.437 | Quality of Life Measurements in Chinese Women with Pelvic Floor Disorders - Validation Study of Pelvic Floor Distress Inventory (PEDI) and Pelvic Floor Impact Questionnaire (PFIQ) | Dr. Chan Shing Chee, Symphorosa |
| 2010.519 | Prospective, Randomized, Double-blind Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients | Dr Chan Shu Yin Eddie |
| 2010.457 | An Open-label Phase Ii Study of TK1258 as Neo-adjuvant Therapy in Patient with Muscle-invasive Bladder Cancer | Dr Chan Shu Yin Eddie |
| 2013.302 | Clinical study to evaluate the efficacy and safety of autologous fibrin sealant in laparoscopic / robotic radical cystectomy | Dr Chan Shu Yin Eddie |
| 2013.223 | A MULTICENTRE STUDY FOR THE EVALUATION OF EFFICACY AND SAFETY OF BUPRENORPHINE TRANSDERMAL PATCH (NORSPANｮ OR SOVENORｮ TRANSDERMAL PATCH)IN PATIENTS WITH NON-MALIGNANT PAIN OF MODERATE TO SEVERE INTENSITY DUE TO OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, LOWER BACK PAIN AND JOINT / MUSCLE PAIN, WHEN AN OPIOID IS NECESSARY FOR OBTAINING ADEQUATE ANALGESIA | Dr. CHAN Simon KC |
| 2013.666 | A Randomized - Control Multi-Centers Study on The Safety and Effectiveness of Peri-Operative Transfusion Trigger Score (POTTS) | Dr Chan Simon Kin Cheong |
| 2016.616 | A multi-center, open-label, single arm, prospective study evaluating the sealing performance of the Shiley™ Laryngeal Mask in a post market clinical follow up (PMCF) |
Dr. CHAN Simon Kin Cheong 陳建昌 |
| 2009.336 | Efficacy of TTS-fentanyl given after weak opioid in patients with cancer related pain without stabilization phase: An open label study | Dr. Chan Simon Kin Cheong |
| 2025.330 | Effectiveness of Virtual Reality-enhanced Interventions on Preoperative Anxiety in Adults Undergoing Elective Surgery: A 3-arm randomised controlled trial (VIPA trial) | Mr. CHAN Sin Lun |
| 2024.172 | Development of virtual reality-enhanced intervention for adults undergoing elective surgery: a qualitative study | Mr. CHAN Sin Lun |
| 2019.273 | Development, implementation and evaluation of a clinical practice guideline for care of preterm infants receiving the non-invasive ventilation: A before and after study |
Ms. CHAN Sin Yee 陳倩儀 |
| 2005.201 | Correlates of Psychological Distress of Patients after Bypass Graft (CABG) Surgery | CHAN SinYi |
| 2014.598 | Postural stability in elderly with toe deformities: a case-control study | Miss Chan Som Yu |
| 2014.103 | The effect of metformin on the outcome of type II diabetic patients with hepatocellular carcinoma | Dr. CHAN Stephen |
| 2017.532 | A Randomized, Open-label, Multi-center Phase III Study of Durvalumab and Tremelimumab as First-line Treatment in Patients with advanced Hepatocellular Carcinoma (HIMALAYA) |
Dr. CHAN Stephen 陳林醫生 |
| 2011.568 | A Randomized, Placebo-controlled, Double-blind, Multicenter Phase II Trial of Intravenous GC33 at 1600 mg Q2W in Previously Treated Patients with Unresectable Advanced or Metastatic Hepatocellular Carcinoma (HCC) | Dr. Chan Stephen |
| 2024.150 | Establishment of New Territories East Cluster Pancreatic Cancer Database | Prof. CHAN Stephen |
| 2017.501 | A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF VARLITINIB PLUS CAPECITABINE VERSUS PLACEBO PLUS CAPECITABINE IN PATIENTS WITH ADVANCED OR METASTATIC BILIARY TRACT CANCER AS SECOND-LINE SYSTEMIC THERAPY |
Dr. CHAN Stephen L. 陳林醫生 |
| 2017.008 | Prospective study on the inflammation environment of hepatocellular carcinoma as signified by the mIBI in patients treated with systemic treatment and immunotherapeutics |
Dr. CHAN Stephen L. 陳林 |
| 2018.396 | A Phase 3, Randomized, Double-blind Study of Adjuvant Nivolumab versus Placebo for Participants with Hepatocellular Carcinoma Who Are at High Risk of Recurrence after Curative Hepatic Resection or Ablation |
Dr. CHAN Stephen L. 陳林醫生 |
| 2013.237 | A Multicenter, Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular Carcinoma | Dr. CHAN Stephen L. |
| 2014.091 | Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres followed by Gemcitabine plus Cisplatin for Intra-hepatic Cholangiocarcinoma: A Phase II study | Dr. CHAN Stephen L. |
| 2014.071 | Detection and quantification of mutations in KIT or PDGFRA with droplet digital PCR in plasma of patients with Gastrointestinal Stromal Tumor (GIST) | Dr. CHAN Stephen L. |
| 2009.296 | Detection of circulating tumor cells in advanced hepatocellular carcinoma undergoing systemic therapy: a pilot study | Prof. Chan Stephen L. |
| 2009.086 | Prospective Study of Reginal Lymph Node Staging by Endoscopic Ultrasound Guided Biopsy in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization | Dr. Chan Stephen L. |
| 2009.441 | Prospective validation of the Chinese University Prognostic Index and Comparison with AJCC TNM, BCLC, CLIP and Okuda's staging system for hepatocellular carcinoma in Asian polulation | Prof. Chan Stephen L. |
| 2009.433 | Evaluation of enlarged regional lymph nodes with endoscopic ultrasound in unresectable hepatocellular carcinoma | Dr. Chan Stephen L. |
| 2022.202 | Real world analysis of sequencing of systemic treatment in hepatocellular carcinoma |
Prof. CHAN Stephen L. 陳林 |
| 2016.074 | A proof-of-concept phase II clinical trial on the use everolimus in TSC2-hull/low hepatocellular carcinoma |
Dr. CHAN Stephen L. 陳林 |
| 2015.090 | Development of clinical model to predict the capecitabine-related toxicity in the Chinese population of colorectal cancer |
Dr. CHAN Stephen L. 陳林 |
| 2017.049 | A phase Ib study of PDR001 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) |
Dr. CHAN Stephen Lam 陳林醫生 |
| 2015.361 | Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ramucirumab and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (AFP) Following First-Line Therapy With Sorafenib |
Dr. CHAN Stephen Lam 陳林 |
| 2016.262 | A Phase III Study of Pembrolizumab (MK-3475) vs. Best Supportive Care as Second-Line Therapy in Subjects with Previously Systemically Treated Advanced Hepatocellular Carcinoma (KEYNOTE-240) |
Dr. CHAN Stephen Lam 陳林醫生 |
| 2017.465 | A clinical trial of pembrolizumab in patients with hepatitis B virus-related hepatocellular carcinoma, with parallel study on baseline and serial change in the immune environment |
Dr. CHAN Stephen Lam 陳林醫生 |
| 2015.072 | A Phase 3, Randomized, Double-blind,Placebo-controlled Study of Gemcitabine and Nab-paclitaxel combined with Momelotinib in Subjects with Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma Preceded by a Dose-finding, Lead-in Phase | Dr. CHAN Stephen Lam |
| 2016.172 | A phase Ib/II, open-label, multi-center study of INC280 in combination with PDR001 or PDR001 single agent in advanced hepatocellular carcinoma |
Dr. CHAN Stephen Lam 陳林醫生 |
Page 63 of 288.